Exploring the feasibility of home-delivered capsule endoscopy with 5G support: innovations and carbon footprint insights.

IF 3.3 Q2 GASTROENTEROLOGY & HEPATOLOGY BMJ Open Gastroenterology Pub Date : 2024-10-31 DOI:10.1136/bmjgast-2024-001500
Gohar Jalayeri Nia, Cassie Conway, Frances Ward, Sheena Dungey, Linda Streames, Bei Bei Liu, Ian Lo Lei, James Cameron, Hagen Wenzek, Chander Shekhar, Sally Eason, Ramesh P Arasaradnam
{"title":"Exploring the feasibility of home-delivered capsule endoscopy with 5G support: innovations and carbon footprint insights.","authors":"Gohar Jalayeri Nia, Cassie Conway, Frances Ward, Sheena Dungey, Linda Streames, Bei Bei Liu, Ian Lo Lei, James Cameron, Hagen Wenzek, Chander Shekhar, Sally Eason, Ramesh P Arasaradnam","doi":"10.1136/bmjgast-2024-001500","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Colorectal cancer (CRC) poses a significant global health threat, necessitating early detection. Traditional diagnostic tools like optical colonoscopy have limitations prompting our '5G-SUCCEEDS' initiative to explore a novel approach involving remote colon capsule endoscopy (CCE).</p><p><strong>Methods: </strong>This prospective feasibility study was conducted at a single hospital in England. Between December 2022 and September 2023, we introduced a remote CCE service within the 5G-SUCCEEDS framework. We undertook a feasibility study of CCE in patients with low-risk/moderate-risk CRC stratified by faecal haemoglobin. Outcomes included carbon footprint analysis (outlined through three potential clinical pathways) and patient-reported outcomes through structured questionnaires and interviews.</p><p><strong>Results: </strong>Among 25 participants, 88% expressed satisfaction with remote CCE. 82% were willing to have remote CCE if clinically indicated in future. CCE findings included adenomatous polyps (58%), normal results (17%) and diverticulosis (21%), with no cancers identified in this pilot. Notably, we found that the carbon footprint associated with delivery of CCE at home (pathway 3) was lower compared with CCE delivered in a clinical setting (pathway 2). A fully optimised, automated scaled-up pathway would combine the delivery and collection of CCE equipment within a local area to reduce the carbon footprint of the travel element by 75%. Moreover, the conversion rate into a colonoscopy pathway is not static and clinicians acknowledge that this could be as low as 28%. Carbon footprint is more favourable for home-delivered CCE in the optimised scenario, while less so when considering the need for additional procedures (colonoscopy conversion).</p><p><strong>Conclusion: </strong>The 5G-SUCCEEDS initiative highlights the feasibility and advantages of home-based diagnostics using CCE.</p>","PeriodicalId":9235,"journal":{"name":"BMJ Open Gastroenterology","volume":null,"pages":null},"PeriodicalIF":3.3000,"publicationDate":"2024-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11529455/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"BMJ Open Gastroenterology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1136/bmjgast-2024-001500","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Colorectal cancer (CRC) poses a significant global health threat, necessitating early detection. Traditional diagnostic tools like optical colonoscopy have limitations prompting our '5G-SUCCEEDS' initiative to explore a novel approach involving remote colon capsule endoscopy (CCE).

Methods: This prospective feasibility study was conducted at a single hospital in England. Between December 2022 and September 2023, we introduced a remote CCE service within the 5G-SUCCEEDS framework. We undertook a feasibility study of CCE in patients with low-risk/moderate-risk CRC stratified by faecal haemoglobin. Outcomes included carbon footprint analysis (outlined through three potential clinical pathways) and patient-reported outcomes through structured questionnaires and interviews.

Results: Among 25 participants, 88% expressed satisfaction with remote CCE. 82% were willing to have remote CCE if clinically indicated in future. CCE findings included adenomatous polyps (58%), normal results (17%) and diverticulosis (21%), with no cancers identified in this pilot. Notably, we found that the carbon footprint associated with delivery of CCE at home (pathway 3) was lower compared with CCE delivered in a clinical setting (pathway 2). A fully optimised, automated scaled-up pathway would combine the delivery and collection of CCE equipment within a local area to reduce the carbon footprint of the travel element by 75%. Moreover, the conversion rate into a colonoscopy pathway is not static and clinicians acknowledge that this could be as low as 28%. Carbon footprint is more favourable for home-delivered CCE in the optimised scenario, while less so when considering the need for additional procedures (colonoscopy conversion).

Conclusion: The 5G-SUCCEEDS initiative highlights the feasibility and advantages of home-based diagnostics using CCE.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
探索在 5G 支持下进行上门胶囊内窥镜检查的可行性:创新和碳足迹见解。
简介结肠直肠癌(CRC)对全球健康构成重大威胁,必须及早发现。光学结肠镜等传统诊断工具存在局限性,这促使我们的 "5G-SUCCEEDS "计划探索一种涉及远程结肠胶囊内镜(CCE)的新方法:这项前瞻性可行性研究在英国一家医院进行。2022 年 12 月至 2023 年 9 月期间,我们在 5G-SUCCEEDS 框架内引入了远程 CCE 服务。我们对按粪便血红蛋白分层的低风险/中度风险 CRC 患者进行了 CCE 可行性研究。研究结果包括碳足迹分析(通过三种可能的临床路径进行概述)以及通过结构化问卷和访谈进行的患者报告结果:结果:在 25 名参与者中,88% 的人对远程 CCE 表示满意。结果:在 25 名参与者中,88% 的人对远程 CCE 表示满意,82% 的人愿意在将来有临床需要时进行远程 CCE。CCE 结果包括腺瘤性息肉(58%)、正常结果(17%)和憩室(21%),本次试验未发现癌症。值得注意的是,我们发现在家进行 CCE(路径 3)与在临床环境中进行 CCE(路径 2)相比,碳足迹更低。经过全面优化的自动化扩大路径将把在当地提供和收集 CCE 设备结合起来,从而将旅行环节的碳足迹减少 75%。此外,结肠镜检查路径的转换率并不是一成不变的,临床医生承认转换率可能低至 28%。在优化方案中,碳足迹更有利于家庭交付的 CCE,而在考虑到需要额外程序(结肠镜检查转换)时,碳足迹就不那么有利了:5G-SUCCEEDS计划凸显了使用CCE进行家庭诊断的可行性和优势。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
BMJ Open Gastroenterology
BMJ Open Gastroenterology GASTROENTEROLOGY & HEPATOLOGY-
CiteScore
5.90
自引率
3.20%
发文量
68
审稿时长
2 weeks
期刊介绍: BMJ Open Gastroenterology is an online-only, peer-reviewed, open access gastroenterology journal, dedicated to publishing high-quality medical research from all disciplines and therapeutic areas of gastroenterology. It is the open access companion journal of Gut and is co-owned by the British Society of Gastroenterology. The journal publishes all research study types, from study protocols to phase I trials to meta-analyses, including small or specialist studies. Publishing procedures are built around continuous publication, publishing research online as soon as the article is ready.
期刊最新文献
Development of a nomogram for predicting pancreatic portal hypertension in patients with acute pancreatitis: a retrospective study. Exploring the feasibility of home-delivered capsule endoscopy with 5G support: innovations and carbon footprint insights. Mixed-method Irish study exploring the role of diet in IBD based on an online questionnaire and a patient panel opinion. Patients and clinicians have different priorities when discussing pain in the IBD clinic. Multicentre study to assess the performance of an artificial intelligence instrument to support qualitative diagnosis of colorectal polyps.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1